Foresee Pharmaceuticals Co Ltd (6576) — Financial Flexibility Index
Foresee Pharmaceuticals Co Ltd (6576) has a Financial Flexibility Index of -0.25x as of June 2025. Free cash flow of NT$-151.26 Million (operating CF NT$-157.53 Million minus capex NT$6.26 Million) represents 0% of total liabilities (NT$593.99 Million). Check cash flow reinvestment rate of Foresee Pharmaceuticals Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Foresee Pharmaceuticals Co Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Foresee Pharmaceuticals Co Ltd across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Foresee Pharmaceuticals Co Ltd generate cash.
Annual Financial Flexibility Index for Foresee Pharmaceuticals Co Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for Foresee Pharmaceuticals Co Ltd. Explore Foresee Pharmaceuticals Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.82x | NT$-1.02 Billion | NT$-1.17 Billion | NT$560.15 Million | ▼ -33.2% |
| 2023 | -1.36x | NT$-841.27 Million | NT$-887.55 Million | NT$616.93 Million | ▼ -206.3% |
| 2022 | -0.45x | NT$-175.16 Million | NT$-233.22 Million | NT$393.43 Million | ▲ +30.5% |
| 2021 | -0.64x | NT$-205.69 Million | NT$-213.33 Million | NT$321.26 Million | ▲ +73.2% |
| 2020 | -2.39x | NT$-646.61 Million | NT$-674.80 Million | NT$270.40 Million | ▲ +24.9% |
| 2019 | -3.19x | NT$-361.29 Million | NT$-447.82 Million | NT$113.40 Million | ▲ +10.5% |
| 2018 | -3.56x | NT$-448.33 Million | NT$-462.43 Million | NT$125.99 Million | ▲ +23.9% |
| 2017 | -4.68x | NT$-465.18 Million | NT$-483.10 Million | NT$99.44 Million | — |